AAAAAA

   
Results: 1-18 |
Results: 18
THE ROLE OF NEURONAL NICOTINIC ACETYLCHOLINE-RECEPTORS IN ANTINOCICEPTION - EFFECTS OF ABT-594
Authors: DECKER MW CURZON P HOLLADAY MW NIKKEL AL BITNER RS BANNON AW DONNELLYROBERTS DL PUTTFARCKEN PS KUNTZWEILER TA BRIGGS CA WILLIAMS M ARNERIC SP
Citation: Mw. Decker et al., THE ROLE OF NEURONAL NICOTINIC ACETYLCHOLINE-RECEPTORS IN ANTINOCICEPTION - EFFECTS OF ABT-594, J PHYSL-PAR, 92(3-4), 1998, pp. 221-224
DISC HERNIATIONS IN THE YOUNG AND END-PLATE VASCULARITY
Authors: CHANDRARAJ S BRIGGS CA OPESKIN K
Citation: S. Chandraraj et al., DISC HERNIATIONS IN THE YOUNG AND END-PLATE VASCULARITY, Clinical anatomy, 11(3), 1998, pp. 171-176
THE ACTIVE USE OF CRUSHERS TO CONTROL PRODUCT REQUIREMENTS
Authors: BEARMAN RA BRIGGS CA
Citation: Ra. Bearman et Ca. Briggs, THE ACTIVE USE OF CRUSHERS TO CONTROL PRODUCT REQUIREMENTS, Minerals engineering, 11(9), 1998, pp. 849-859
ACTIVATION AND INHIBITION OF THE HUMAN ALPHA-7 NICOTINIC ACETYLCHOLINE-RECEPTOR BY AGONISTS
Authors: BRIGGS CA MCKENNA DG
Citation: Ca. Briggs et Dg. Mckenna, ACTIVATION AND INHIBITION OF THE HUMAN ALPHA-7 NICOTINIC ACETYLCHOLINE-RECEPTOR BY AGONISTS, Neuropharmacology, 37(9), 1998, pp. 1095-1102
ABT-594 [(R)-5-(2-AZETIDINYLMETHOXY)-2-CHLOROPYRIDINE] - A NOVEL, ORALLY EFFECTIVE ANALGESIC ACTING VIA NEURONAL NICOTINIC ACETYLCHOLINE-RECEPTORS - I - IN-VITRO CHARACTERIZATION
Authors: DONNELLYROBERTS DL PUTTFARCKEN PS KUNTZWEILER TA BRIGGS CA ANDERSON DJ CAMPBELL JE PIATTONIKAPLAN M MCKENNA DG WASICAK JT HOLLADAY MW WILLIAMS M ARNERIC SP
Citation: Dl. Donnellyroberts et al., ABT-594 [(R)-5-(2-AZETIDINYLMETHOXY)-2-CHLOROPYRIDINE] - A NOVEL, ORALLY EFFECTIVE ANALGESIC ACTING VIA NEURONAL NICOTINIC ACETYLCHOLINE-RECEPTORS - I - IN-VITRO CHARACTERIZATION, The Journal of pharmacology and experimental therapeutics, 285(2), 1998, pp. 777-786
IDENTIFICATION AND INITIAL STRUCTURE-ACTIVITY-RELATIONSHIPS OF 5-(2-AZETIDINYLMETHOXY)-2-CHLOROPYRIDINE(ABT-594), A POTENT, ORALLY-ACTIVE, NONOPIATE ANALGESIC AGENT ACTING VIA NEURONAL NICOTINIC ACETYLCHOLINE-RECEPTORS
Authors: HOLLADAY MW WASICAK JT LIN NH HE Y RYTHER KB BANNON AW BUCKLEY MJ KIM DJB DECKER MW ANDERSON DJ CAMPBELL JE KUNTZWEILER TA DONNELLYROBERTS DL PIATTONIKAPLAN M BRIGGS CA WILLIAMS M ARNERIC SP
Citation: Mw. Holladay et al., IDENTIFICATION AND INITIAL STRUCTURE-ACTIVITY-RELATIONSHIPS OF 5-(2-AZETIDINYLMETHOXY)-2-CHLOROPYRIDINE(ABT-594), A POTENT, ORALLY-ACTIVE, NONOPIATE ANALGESIC AGENT ACTING VIA NEURONAL NICOTINIC ACETYLCHOLINE-RECEPTORS, Journal of medicinal chemistry, 41(4), 1998, pp. 407-412
IN PURSUIT OF HIGHER PURITY - USE OF C-13 NMR AND C-13-ENRICHED SUBSTRATES TO TRACE IMPURITY GENERATION AND REMOVAL IN THE SYNTHESIS OF ATORVASTATIN
Authors: WADE RA ZENNIE TM BRIGGS CA JENNINGS RA NANNINGA TN PALMER CW CLAY RJ
Citation: Ra. Wade et al., IN PURSUIT OF HIGHER PURITY - USE OF C-13 NMR AND C-13-ENRICHED SUBSTRATES TO TRACE IMPURITY GENERATION AND REMOVAL IN THE SYNTHESIS OF ATORVASTATIN, Organic process research & development, 1(4), 1997, pp. 320-324
THE APPLICATION OF ROCK MECHANICS PARAMETERS TO THE PREDICTION OF COMMINUTION BEHAVIOR
Authors: BEARMAN RA BRIGGS CA KOJOVIC T
Citation: Ra. Bearman et al., THE APPLICATION OF ROCK MECHANICS PARAMETERS TO THE PREDICTION OF COMMINUTION BEHAVIOR, Minerals engineering, 10(3), 1997, pp. 255-264
FUNCTIONAL-CHARACTERIZATION OF THE NOVEL NEURONAL NICOTINIC ACETYLCHOLINE-RECEPTOR LIGAND GTS-21 IN-VITRO AND IN-VIVO
Authors: BRIGGS CA ANDERSON DJ BRIONI JD BUCCAFUSCO JJ BUCKLEY MJ CAMPBELL JE DECKER MW DONNELLYROBERTS D ELLIOTT RL GOPALAKRISHNAN M HOLLADAY MW HUI YH JACKSON WJ KIM DJB MARSH KC ONEILL A PRENDERGAST MA RYTHER KB SULLIVAN JP ARNERIC SP
Citation: Ca. Briggs et al., FUNCTIONAL-CHARACTERIZATION OF THE NOVEL NEURONAL NICOTINIC ACETYLCHOLINE-RECEPTOR LIGAND GTS-21 IN-VITRO AND IN-VIVO, Pharmacology, biochemistry and behavior, 57(1-2), 1997, pp. 231-241
ABT-089 [2-METHYL-3(2-(S)-PYRROLIDINYLMETHOXY)PYRIDINE] .1. A POTENT AND SELECTIVE CHOLINERGIC CHANNEL MODULATOR WITH NEUROPROTECTIVE PROPERTIES
Authors: SULLIVAN JP DONNELLYROBERTS D BRIGGS CA ANDERSON DJ GOPALAKRISHNAN M XUE IC PLATTONIKAPLAN M MOLINARI E CAMPBELL JE MCKENNA DG GUNN DE LIN NH RYTHER KB HE Y HOLLADAY MW WONNACOTT S WILLIAMS M ARNERIC SP
Citation: Jp. Sullivan et al., ABT-089 [2-METHYL-3(2-(S)-PYRROLIDINYLMETHOXY)PYRIDINE] .1. A POTENT AND SELECTIVE CHOLINERGIC CHANNEL MODULATOR WITH NEUROPROTECTIVE PROPERTIES, The Journal of pharmacology and experimental therapeutics, 283(1), 1997, pp. 235-246
AN INVESTIGATION OF ROCK BREAKAGE AND DAMAGE IN COMMINUTION EQUIPMENT
Authors: BRIGGS CA BEARMAN RA
Citation: Ca. Briggs et Ra. Bearman, AN INVESTIGATION OF ROCK BREAKAGE AND DAMAGE IN COMMINUTION EQUIPMENT, Minerals engineering, 9(5), 1996, pp. 489-497
EFFECTS OF THE CHOLINERGIC CHANNEL ACTIVATOR ABT-418 ON CORTICAL EEG - COMPARISON WITH (-)-NICOTINE
Authors: RADEK RJ BRIGGS CA SULLIVAN JP KANG CH ARNERIC SP
Citation: Rj. Radek et al., EFFECTS OF THE CHOLINERGIC CHANNEL ACTIVATOR ABT-418 ON CORTICAL EEG - COMPARISON WITH (-)-NICOTINE, Drug development research, 37(2), 1996, pp. 73-79
A-85380 [3-(2(S)-AZETIDINYLMETHOXY)PYRIDINE] - IN-VITRO PHARMACOLOGICAL PROPERTIES OF A NOVEL, HIGH-AFFINITY ALPHA-4-BETA-2 NICOTINIC ACETYLCHOLINE-RECEPTOR LIGAND
Authors: SULLIVAN JP DONNELLYROBERTS D BRIGGS CA ANDERSON DJ GOPALAKRISHNAN M PIATTONIKAPLAN M CAMPBELL JE MCKENNA DG MOLINARI E HETTINGER AM GARVEY DS WASICAK JT HOLLADAY MW WILLIAMS M ARNERIC SP
Citation: Jp. Sullivan et al., A-85380 [3-(2(S)-AZETIDINYLMETHOXY)PYRIDINE] - IN-VITRO PHARMACOLOGICAL PROPERTIES OF A NOVEL, HIGH-AFFINITY ALPHA-4-BETA-2 NICOTINIC ACETYLCHOLINE-RECEPTOR LIGAND, Neuropharmacology, 35(6), 1996, pp. 725-734
EFFECT OF MK-801 AT THE HUMAN ALPHA-7 NICOTINIC ACETYLCHOLINE-RECEPTOR
Authors: BRIGGS CA MCKENNA DG
Citation: Ca. Briggs et Dg. Mckenna, EFFECT OF MK-801 AT THE HUMAN ALPHA-7 NICOTINIC ACETYLCHOLINE-RECEPTOR, Neuropharmacology, 35(4), 1996, pp. 407-414
POTENTIAL TREATMENT OF ALZHEIMER-DISEASE USING CHOLINERGIC CHANNEL ACTIVATORS (CHCAS) WITH COGNITIVE ENHANCEMENT, ANXIOLYTIC-LIKE, AND CYTOPROTECTIVE PROPERTIES
Authors: ARNERIC SP SULLIVAN JP DECKER MW BRIONI JD BANNON AW BRIGGS CA DONNELLYROBERTS D RADEK RJ MARSH KC KYNCL J WILLIAMS M BUCCAFUSCO JJ
Citation: Sp. Arneric et al., POTENTIAL TREATMENT OF ALZHEIMER-DISEASE USING CHOLINERGIC CHANNEL ACTIVATORS (CHCAS) WITH COGNITIVE ENHANCEMENT, ANXIOLYTIC-LIKE, AND CYTOPROTECTIVE PROPERTIES, Alzheimer disease and associated disorders, 9, 1995, pp. 50-61
GANGLIONIC NICOTINIC ACETYLCHOLINE-RECEPTOR ACTIVATION BY THE NOVEL AGONIST ABT-418
Authors: BRIGGS CA HUGHES ML MONTEGGIA LM GIORDANO T DONNELLYROBERTS D ARNERIC SP
Citation: Ca. Briggs et al., GANGLIONIC NICOTINIC ACETYLCHOLINE-RECEPTOR ACTIVATION BY THE NOVEL AGONIST ABT-418, Drug development research, 34(1), 1995, pp. 39-46
HUMAN ALPHA-7 NICOTINIC ACETYLCHOLINE-RECEPTOR RESPONSES TO NOVEL LIGANDS
Authors: BRIGGS CA MCKENNA DG PIATTONIKAPLAN M
Citation: Ca. Briggs et al., HUMAN ALPHA-7 NICOTINIC ACETYLCHOLINE-RECEPTOR RESPONSES TO NOVEL LIGANDS, Neuropharmacology, 34(6), 1995, pp. 583-590
(S)-3-METHYL-5-(1-METHYL-2-PYRROLIDINYL)ISOXAZOLE (ABT-418) - A NOVELCHOLINERGIC LIGAND WITH COGNITION-ENHANCING AND ANXIOLYTIC ACTIVITIES.1. IN-VITRO CHARACTERIZATION
Authors: ARNERIC SP SULLIVAN JP BRIGGS CA DONNELLYROBERTS D ANDERSON DJ RASZKIEWICZ JL HUGHES ML CADMAN ED ADAMS P GARVEY DS WASICAK JT WILLIAMS M
Citation: Sp. Arneric et al., (S)-3-METHYL-5-(1-METHYL-2-PYRROLIDINYL)ISOXAZOLE (ABT-418) - A NOVELCHOLINERGIC LIGAND WITH COGNITION-ENHANCING AND ANXIOLYTIC ACTIVITIES.1. IN-VITRO CHARACTERIZATION, The Journal of pharmacology and experimental therapeutics, 270(1), 1994, pp. 310-318
Risultati: 1-18 |